Clinical Trial Update: The Efficacy of the Administration of Fibrinogen in Liver Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether administering fibrinogen during liver transplantation reduces intraoperative bleeding; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Disease
• Liver Failure

Drugs mentioned

• Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Intraoperative Bleeding | Phase 3 | Status: UNKNOWN